Liang Mu

机构：Harbin University

发表论文 24 篇 · 总被引 268 次 · h-index 6

代表论文

• The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity (2023 · Nature · 被引 180)
• Comparative efficacy of exercise modalities for cardiopulmonary function in hemodialysis patients: A systematic review and network meta-analysis (2022 · Frontiers in Public Health · 被引 29)
• [Study on antidepressant components of sucrose ester from Polygala tenuifolia]. (2008 · PubMed · 被引 15)
• A modified CEUS risk stratification model for adnexal masses with solid components: prospective multicenter study and risk adjustment (2024 · European Radiology · 被引 12)
• Integrating Contrast-enhanced US to O-RADS US for Classification of Adnexal Lesions with Solid Components: Time-intensity Curve Analysis versus Visual Assessment (2024 · Radiology Imaging Cancer · 被引 8)
• Abstract ND06: ABBV-CLS-484: An active site PTPN2/N1 inhibitor that augments the immune response and sensitizes tumors to immune-mediated killing (2022 · Cancer Research · 被引 7)